Champlain Investment Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-7,000	Closed	-$254K	–	118
2016 Q4	$254K	Buy	7,000 +500	+8%	+$18.1K	﹤0.01%	119
2016 Q3	$299K	Buy	+6,500	New	+$299K	﹤0.01%	130